mdi Consultants
CST Technologies, Inc. has been a longtime client of MDI, and we’re proud to have played a role in helping them reach this milestone.
CST Technologies: Engineering the Future of Diagnostics
Life Sciences Reiew
Before synthetic biology captured headlines, CST Technologies was already reshaping the diagnostics landscape. For over four decades, the company has specialized in developing synthetic serum and urine matrices— delivering contamination-free, scalable, and highly stable solutions that have become the backbone of some of the industry’s most trusted diagnostic controls. By replacing inconsistent biological materials with engineered precision, CST Technologies helped set new benchmarks long before the world caught on.
The company’s impact on in vitro diagnostic (IVD) manufacturing has been profound. With products that eliminate lot-to-lot variation and coldchain dependencies, CST offers a rare combination of consistency, reliability, and peace of mind. Its unwavering commitment to quality has earned CST a reputation as a silent standard-bearer for laboratories and manufacturers worldwide.
CST’s journey began in the early 1980s when the diagnostics industry heavily relied on human and bovine serum albumin (HSA and BSA) to produce controls and standards. Though common, these biologics presented serious challenges: unpredictable batch variability, sensitivity to temperature fluctuations, and heightened safety risks amid the AIDS and hepatitis epidemics.
During this turbulent period, CST’s late co-founder, Dr. Anand Akerkar, recognized the urgent need for a safer and more dependable alternative. A Ph.D. chemist with a passion for solving real-world problems, Dr. Akerkar pioneered the development of synthetic matrices designed to replace HSA and BSA. His groundbreaking work culminated in creating CST’s flagship innovations—SERASUB, URISUB, and LOSOURISUB.
These synthetic solutions did more than eliminate the risks associated with biological materials; they revolutionized diagnostic manufacturing. Offering room-temperature stability and eliminating batch inconsistencies, CST’s matrices became a critical advancement that continues supporting global healthcare infrastructure today.